Semaglutide has emerged as a novel treatment for insulin resistance. This manufactured glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and curbing glucagon https://sachindceu649981.ka-blogs.com/88933773/comprehending-semaglutide-a-comprehensive-guide